Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M86.4Revenue $M4.8Net Margin (%)-2,481.8Z-Score-6.9
Enterprise Value $M29.4EPS $-6.1Operating Margin %-2,482.6F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-2,485.8Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %0Quick Ratio4.7Cash flow > EarningsN
Price/Sales30.25-y EBITDA Growth Rate %0Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-71.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-100.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.7ROI % (ttm)-164.1Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTXGeorge Soros 2014-09-30 Sold Out $4.325 - $5.64
($5.07)
$ 3.98-22%Sold Out0
ONTXGeorge Soros 2014-06-30 Buy $4.18 - $6.22
($5.24)
$ 3.98-24%New holding, 10774 sh.10,774
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ONTX George Soros 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy143,480$8.47-53.48view
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy143,480$8.47-53.48view
Kumar RameshPresident and CEO 2014-02-10Sell33,543$15.07-73.86view
Kumar RameshPresident and CEO 2014-02-03Sell60,000$15.05-73.82view
Michael & Jane Hoffman 2013 De10% Owner 2014-01-27Buy57,295$11.92-66.95view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy57,295$11.92-66.95view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-22Buy5,000$14.39-72.62view
Hoffman Michael BDirector, 10% Owner 2013-11-22Buy5,000$14.39-72.62view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-18Buy5,000$11.87-66.81view
Hoffman Michael BDirector, 10% Owner 2013-11-18Buy5,000$11.87-66.81view

Press Releases about ONTX :

    Quarterly/Annual Reports about ONTX:

    News about ONTX:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    Nasdaq stocks posting largest percentage increases Dec 16 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 10 2014
    Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting Dec 07 2014
    Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting Dec 07 2014
    Onconova Announces Data Presentation From Combination of Rigosertib and Azacitidine in MDS and... Dec 07 2014
    Onconova Announces Data Presentation From Combination of Rigosertib and Azacitidine in MDS and... Dec 07 2014
    Onconova Therapeutics to Host Analyst Event in New York City on December 12, 2014 Dec 05 2014
    Onconova Therapeutics to Host Analyst Event in New York City on December 12, 2014 Dec 05 2014
    ONCONOVA THERAPEUTICS, INC. Financials Nov 21 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Nov 14 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 13 2014
    Onconova Therapeutics, Inc. Reports Third Quarter 2014 Financial and Operational Results Nov 13 2014
    Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting Nov 06 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Nov 06 2014
    Onconova Announces Ten Presentations at the 2014 ASH Annual Meeting Nov 06 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Oct 08 2014
    Merrimack Does Well to License Marginal Cancer Drug to Baxter Sep 24 2014
    5 Breakout Stocks Under $10 Set to Soar Aug 15 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Aug 14 2014
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK